You are using an outdated browser. Please upgrade your browser to improve your experience.

tazemetostat

Tazemetostat is an inhibitor of the methyltransferase, EZH2, and some EZH2 gain-of-function mutations including Y646X and A687V. Tazemetostat also inhibited EZH1 with a half-maximal inhibitory concentration (IC50) of 392 nM, approximately 36 times higher than the IC50 for inhibition of EZH2
Target Activities
Items per page:
10
1 – 2 of 2